Page 40 - Pharma

Aerosol propellant market to reach $8.16 bn by 2020

Personal care & homecare products, environment regulations, increase in the disposable income, etc are driving the aerosol propellant market, according to MarketsandMarkets' report

Cipla sells stake in biotech arm Biomab Holding

The company will focus on global development under Cipla BioTec, which will focus on research, development, manufacturing and marketing of biosimilars

Natco launches hepatitis C drug Hepcinat LP in Nepal

Hepcinat LP, a two-drug fixed-dose combination product that contains ledipasvir and sofosbuvir, is the generic version of Gilead Sciences' Harvoni drug

Natural Capsules plans to invest Rs 25 cr for capacity expansion

While the company will enhance gelatin capsules capacity at Pondicherry unit, it will upgrade and convert the existing three gelatin capsules lines to HPMC (vegetarian) lines at Bangalore

Glenmark receives tentative approval from US FDA for lacosamide tablets

Lacosamide tablets are the generic version of UCB's Vimpat tablets, which recorded annual sales of approximately $ 691 million in the US

Merck inks drug discovery collaboration pact with Polish firm Selvita

The aim of the collaboration is to deliver potential first-in-class small molecules as lead candidate drugs for multiple oncology indications

Sanofi and RSSDI organise walkathon for diabetes control in Lucknow

Through this Walkathon, Sanofi and RSSDI shared the message that a physically active lifestyle contributes significantly to more effective management of diabetes

Indian Immunologicals' bovine serum facility in New Zealand starts operation

The objective of the investment in the New Zealand facility was to gain control over the supplies of a key ingredient (serum) used in vaccine manufacture

Lupin receives US FDA nod for dementia and contraceptive drugs

The company has received US drug regulator's approvals for generic versions of Eisai Inc's Aricept and Warner Chilcott's Loestrin 24 Fe tablets

Evonik expands specialty silica capacity in Japan

Specialty silicas are used in beer filtration, as drug carriers in pharmaceuticals, and as flow aids in powdered foods and thickener for toothpastes

India and South Africa to strengthen research collaboration

Two countries are collaborating in key areas such as health sciences, biotechnology, green chemistry, etc and also on HIV vaccine research project

Glenmark inks licensing pact with Polish firm Celon for inhaler

The company bags semi-exclusive marketing & distribution rights for fluticasone/salmeterol dry powder inhaler - a generic version of GlaxoSmithKline's Seretide Accuhaler - in Europe

Lupin appoints Fabrice Egros as Asia-Pacific head

Egros Fabrice will be responsible for Lupin's growth and development across key markets such as Japan, Australia, the Philippines and South East Asia

Strides Arcolab buys brands from J&J and stake in Medispan

With the acquisition of stake in Medispan, a pharmaceutical unit of Shriram Group, Strides Arcolab has gained entry into niche probiotics segment

Aurobindo Pharma receives US FDA nod for painkiller tramadol tabs

According to IMS, the approved product has an estimated market size of $ 56 million for the twelve months ending August 2015

Sigma-Aldrich sells solvents and inorganics biz to Honeywell

The company sold parts of its business in Europe for fulfilling the commitments made to the EU in order to win antitrust approval for Merck's $ 17-billion acquisition of Sigma-Aldrich

US FDA grants approval to Jubilant Life's migraine drug rizatriptan

Rizatriptan benzoate orally disintegrating tablet is the generic version of Merck's Maxalt-MLT tablet

Recipharm buys 74% stake in Nitin Lifesciences for Rs 671 crore

With this, Swedish firm Recipharma aims to bolster its presence in the rapidly expanding Indian market and consolidate its position in the global sterile injectables segment

Kilitch Drugs forms JV in Ethiopia

The JV, in which Kilitch will hold 97 percent, will set up manufacturing facility for pharmaceuticals in Ethiopia

Unichem receives US FDA approval for hypertension drug losartan

The product will be commercialised from Unichem's Ghaziabad plant, while active pharmaceutical ingredients will be made at Pithampur API plant in Madhya Pradesh